CTW, a leading game platform company known for its web-based games inspired by Japanese anime, announced its participation in the BMO Capital Markets Technology and Innovation Leaders Conference on November 12, 2026, in New York. This follows CTW's Nasdaq listing in August 2025 and the opening of its North American office in New York City in February 2026, marking its efforts to expand in the U.S. capital markets. At the conference, CTW will discuss its unique business model, licensed anime and manga IP portfolio, user acquisition strategy, and long-term growth plans. The event aims to enhance CTW's engagement with the North American investment community and broaden its institutional shareholder base.
CTW's participation in the BMO Capital Markets Technology and Innovation Leaders Conference is the subject here. For readers following Technology-sector US stocks on Pluang, 21 of 150 priced stocks rose while 127 fell. Notable movers include CTSH at USD 59.00 with a -11.09% change, AXTI at USD 59.48 with a -7.61% change, and ZS at USD 236.40 with a -7.58% change. This data is as of Oct 29, 2026 19:13 WIB.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
